Healthcare -
Biotechnology - NASDAQ - US
$ 36.2
-0.958 %
$ 10.3 B
Market Cap
23.35
P/E
EXEL - CAPITAL EXPENDITURES
Capital Expenditures EXEL - Exelixis, Inc.
-163 M
LAST VALUE
-59.29%
2 YEAR CAGR
-37.39%
5 YEAR CAGR
-54.01%
10 YEAR CAGR